Literature DB >> 30602612

High Permissiveness for Genetic Exchanges between Enteroviruses of Species A, including Enterovirus 71, Favors Evolution through Intertypic Recombination in Madagascar.

Romain Volle1,2, Richter Razafindratsimandresy3, Marie-Line Joffret1,2, Maël Bessaud1,2, Sendraharimanana Rabemanantsoa3, Seta Andriamamonjy3, Jonhson Raharinantoanina3, Bruno Blondel1,2, Jean-Michel Heraud3, Jean-Luc Bailly4, Francis Delpeyroux5,2.   

Abstract

Human enteroviruses of species A (EV-A) are the leading cause of hand-foot-and-mouth disease (HFMD). EV-A71 is frequently implicated in HFMD outbreaks and can also cause severe neurological manifestations. We investigated the molecular epidemiological processes at work and the contribution of genetic recombination to the evolutionary history of EV-A in Madagascar, focusing on the recently described EV-A71 genogroup F in particular. Twenty-three EV-A isolates, collected mostly in 2011 from healthy children living in various districts of Madagascar, were characterized by whole-genome sequencing. Eight different types were identified, highlighting the local circulation and diversity of EV-A. Comparative genome analysis revealed evidence of frequent recent intra- and intertypic genetic exchanges between the noncapsid sequences of Madagascan EV-A isolates. The three EV-A71 isolates had different evolutionary histories in terms of recombination, with one isolate displaying a mosaic genome resulting from recent genetic exchanges with Madagascan coxsackieviruses A7 and possibly A5 and A10 or common ancestors. The engineering and characterization of recombinants generated from progenitors belonging to different EV-A types or EV-A71 genogroups with distantly related nonstructural sequences indicated a high level of permissiveness for intertypic genetic exchange in EV-A. This permissiveness suggests that the primary viral functions associated with the nonstructural sequences have been highly conserved through the diversification and evolution of the EV-A species. No outbreak of disease due to EV-A has yet been reported in Madagascar, but the diversity, circulation, and evolution of these viruses justify surveillance of EV-A circulation and HFMD cases to prevent possible outbreaks due to emerging strains.IMPORTANCE Human enteroviruses of species A (EV-A), including EV-A71, are the leading cause of hand-foot-and-mouth disease (HFMD) and may also cause severe neurological manifestations. We investigated the circulation and molecular evolution of EV-A in Madagascar, focusing particularly on the recently described EV-A71 genogroup F. Eight different types, collected mostly in 2011, were identified, highlighting the local circulation and diversity of EV-A. Comparative genome analysis revealed evidence of frequent genetic exchanges between the different types of isolates. The three EV-A71 isolates had different evolutionary histories in terms of recombination. The engineering and characterization of recombinants involving progenitors belonging to different EV-A types indicated a high degree of permissiveness for genetic exchange in EV-A. No outbreak of disease due to EV-A has yet been reported in Madagascar, but the diversity, circulation, and evolution of these viruses justify the surveillance of EV-A circulation to prevent possible HFMD outbreaks due to emerging strains.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  RNA virus; emergence; enterovirus; picornavirus; recombination; viral evolution

Mesh:

Year:  2019        PMID: 30602612      PMCID: PMC6401452          DOI: 10.1128/JVI.01667-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Natural genetic recombination between co-circulating heterotypic enteroviruses.

Authors:  Gabriela Oprisan; Mariana Combiescu; Sophie Guillot; Valerie Caro; Andrei Combiescu; Francis Delpeyroux; Radu Crainic
Journal:  J Gen Virol       Date:  2002-09       Impact factor: 3.891

Review 2.  Virus world as an evolutionary network of viruses and capsidless selfish elements.

Authors:  Eugene V Koonin; Valerian V Dolja
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

Review 3.  Virology, epidemiology, pathogenesis, and control of enterovirus 71.

Authors:  Tom Solomon; Penny Lewthwaite; David Perera; Mary Jane Cardosa; Peter McMinn; Mong How Ooi
Journal:  Lancet Infect Dis       Date:  2010-10-18       Impact factor: 25.071

4.  Evidence of recombination among enteroviruses.

Authors:  J Santti; T Hyypiä; L Kinnunen; M Salminen
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

5.  Recombination in circulating enteroviruses.

Authors:  Alexander N Lukashev; Vasilii A Lashkevich; Olga E Ivanova; Galina A Koroleva; Ari E Hinkkanen; Jorma Ilonen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Molecular epidemiology and the evolution of human coxsackievirus A6.

Authors:  Jiratchaya Puenpa; Sompong Vongpunsawad; Riikka Österback; Matti Waris; Eva Eriksson; Jan Albert; Sofie Midgley; Thea K Fischer; Anna M Eis-Hübinger; María Cabrerizo; Eleanor Gaunt; Peter Simmonds; Yong Poovorawan
Journal:  J Gen Virol       Date:  2016-09-29       Impact factor: 3.891

Review 7.  Picornavirus and enterovirus diversity with associated human diseases.

Authors:  Caroline Tapparel; Fredy Siegrist; Tom J Petty; Laurent Kaiser
Journal:  Infect Genet Evol       Date:  2012-11-29       Impact factor: 3.342

8.  Fourteen types of co-circulating recombinant enterovirus were associated with hand, foot, and mouth disease in children from Wenzhou, China.

Authors:  Wen-Ping Guo; Xian-Dan Lin; Yi-Ping Chen; Qi Liu; Wen Wang; Cai-Qiao Wang; Ming-Hui Li; Xiao-Yu Sun; Mang Shi; Edward C Holmes; Yong-Zhen Zhang
Journal:  J Clin Virol       Date:  2015-07-02       Impact factor: 3.168

9.  Detection of non-polio enteroviruses from 17 years of virological surveillance of acute flaccid paralysis in the Philippines.

Authors:  Lea Necitas Apostol; Akira Suzuki; Analisa Bautista; Hazel Galang; Fem Julia Paladin; Naoko Fuji; Socorro Lupisan; Remigio Olveda; Hitoshi Oshitani
Journal:  J Med Virol       Date:  2012-04       Impact factor: 2.327

10.  Genetic characterization of human coxsackievirus A6 variants associated with atypical hand, foot and mouth disease: a potential role of recombination in emergence and pathogenicity.

Authors:  Eleanor Gaunt; Heli Harvala; Riikka Österback; Vattipally B Sreenu; Emma Thomson; Matti Waris; Peter Simmonds
Journal:  J Gen Virol       Date:  2015-01-22       Impact factor: 3.891

View more
  5 in total

1.  Genetic diversity and evolution of enterovirus A71 subgenogroup C1 from children with hand, foot, and mouth disease in Thailand.

Authors:  Jiratchaya Puenpa; Kamol Suwannakarn; Jira Chansaenroj; Chompoonut Auphimai; Nasamon Wanlapakorn; Sompong Vongpunsawad; Yong Poovorawan
Journal:  Arch Virol       Date:  2021-06-04       Impact factor: 2.574

2.  The Establishment of Infectious Clone and Single Round Infectious Particles for Coxsackievirus A10.

Authors:  Min Wang; Jingjing Yan; Liuyao Zhu; Meng Wang; Lizhen Liu; Rui Yu; Ming Chen; Jingna Xun; Yuling Zhang; Zhigang Yi; Shuye Zhang
Journal:  Virol Sin       Date:  2020-03-06       Impact factor: 4.327

3.  Characterization of Plaque Variants and the Involvement of Quasi-Species in a Population of EV-A71.

Authors:  Madiiha Bibi Mandary; Malihe Masomian; Seng-Kai Ong; Chit Laa Poh
Journal:  Viruses       Date:  2020-06-17       Impact factor: 5.048

Review 4.  Recombination in Enteroviruses, a Multi-Step Modular Evolutionary Process.

Authors:  Claire Muslin; Alice Mac Kain; Maël Bessaud; Bruno Blondel; Francis Delpeyroux
Journal:  Viruses       Date:  2019-09-14       Impact factor: 5.048

5.  Global Spread of the B5 Subgenotype EV-A71 and the Phylogeographical Analysis of Chinese Migration Events.

Authors:  Keqiang Huang; Yong Zhang; Zhenzhi Han; Xiaofang Zhou; Yang Song; Dongyan Wang; Shuangli Zhu; Dongmei Yan; Wen Xu; Wenbo Xu
Journal:  Front Cell Infect Microbiol       Date:  2020-09-25       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.